T1	B-Protein	0	1	c	c	O	SYM	O	0	ROOT	O
T1	I-Protein	1	2	-	-	O	:	O	1	P	O
T1	I-Protein	2	5	Maf	Maf	B-NP	NN	B-protein	4	SUB	B-protein
O	O	6	13	induces	induce	B-VP	VBZ	O	1	VMOD	O
O	O	14	23	monocytic	monocytic	B-NP	JJ	O	6	NMOD	O
O	O	24	39	differentiation	differentiation	I-NP	NN	O	8	NMOD	O
O	O	40	43	and	and	I-NP	CC	O	8	NMOD	O
O	O	44	53	apoptosis	apoptosis	I-NP	NN	O	4	OBJ	O
O	O	54	56	in	in	B-PP	IN	O	4	VMOD	O
O	O	57	65	bipotent	bipotent	B-NP	JJ	B-cell_type	12	NMOD	B-cell_type
O	O	66	73	myeloid	myeloid	I-NP	JJ	I-cell_type	12	NMOD	I-cell_type
O	O	74	85	progenitors	progenitor	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	85	86	.	.	O	.	O	1	P	O

O	O	88	91	The	The	B-NP	DT	O	3	NMOD	O
O	O	92	107	transcriptional	transcriptional	I-NP	JJ	O	3	NMOD	O
O	O	108	118	mechanisms	mechanism	I-NP	NNS	O	31	SUB	O
O	O	119	123	that	that	B-NP	WDT	O	3	NMOD	O
O	O	124	129	drive	drive	B-VP	VBP	O	4	SBAR	O
O	O	130	136	colony	colony	B-NP	NN	O	5	OBJ	O
O	O	136	137	-	-	O	HYPH	O	6	P	O
O	O	137	144	forming	form	B-VP	VBG	O	6	NMOD	O
O	O	145	149	unit	unit	B-NP	NN	O	12	NMOD	O
O	O	150	161	granulocyte	granulocyte	I-NP	NN	O	12	NMOD	O
O	O	161	162	-	-	B-NP	HYPH	O	12	NMOD	O
O	O	162	172	macrophage	macrophage	I-NP	NN	B-cell_type	19	NMOD	B-cell_type
O	O	173	174	(	(	O	(	O	17	DEP	O
O	O	174	177	CFU	CFU	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	177	178	-	-	B-NP	HYPH	O	16	P	O
O	O	178	180	GM	GM	I-NP	NN	O	17	DEP	O
O	O	180	181	)	)	O	)	O	12	NMOD	O
O	O	182	189	myeloid	myeloid	B-NP	JJ	O	19	NMOD	O
O	O	190	201	progenitors	progenitor	I-NP	NNS	O	8	OBJ	O
O	O	202	204	to	to	B-VP	TO	O	21	VMOD	O
O	O	205	218	differentiate	differentiate	I-VP	VB	O	8	VMOD	O
O	O	219	223	into	into	B-PP	IN	O	21	VMOD	O
O	O	224	229	cells	cell	B-NP	NNS	O	22	PMOD	O
O	O	230	232	of	of	B-PP	IN	O	23	NMOD	O
O	O	233	239	either	either	O	CC	O	30	NMOD	O
O	O	240	243	the	the	B-NP	DT	O	30	NMOD	O
O	O	244	256	granulocytic	granulocytic	I-NP	JJ	B-cell_type	30	NMOD	B-cell_type
O	O	257	259	or	or	I-NP	CC	I-cell_type	30	NMOD	I-cell_type
O	O	260	269	monocytic	monocytic	I-NP	JJ	I-cell_type	30	NMOD	I-cell_type
O	O	270	277	lineage	lineage	I-NP	NN	I-cell_type	24	PMOD	I-cell_type
O	O	278	281	are	be	B-VP	VBP	O	0	ROOT	O
O	O	282	285	not	not	I-VP	RB	O	31	VMOD	O
O	O	286	291	fully	fully	I-VP	RB	O	31	VMOD	O
O	O	292	302	understood	understand	I-VP	VBN	O	31	VC	O
O	O	302	303	.	.	O	.	O	31	P	O

O	O	304	306	We	We	B-NP	PRP	O	2	SUB	O
O	O	307	311	have	have	B-VP	VBP	O	0	ROOT	O
O	O	312	317	shown	show	I-VP	VBN	O	2	VC	O
O	O	318	322	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	323	326	the	the	B-NP	DT	O	14	NMOD	O
T2	B-Protein	327	328	c	c	I-NP	NN	O	14	NMOD	O
T2	I-Protein	328	329	-	-	B-NP	HYPH	O	14	P	O
T2	I-Protein	329	332	Maf	Maf	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	333	336	and	and	I-NP	CC	O	10	NMOD	O
T3	B-Protein	337	338	c	c	I-NP	NN	O	14	NMOD	O
T3	I-Protein	338	339	-	-	B-NP	HYPH	O	14	NMOD	O
T3	I-Protein	339	342	Myb	Myb	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	343	356	transcription	transcription	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	357	364	factors	factor	I-NP	NNS	I-protein	16	SUB	I-protein
O	O	365	375	physically	physically	B-ADVP	RB	O	16	VMOD	O
O	O	376	384	interact	interact	B-VP	VBP	O	4	SBAR	O
O	O	385	387	in	in	B-PP	IN	O	16	VMOD	O
O	O	388	395	myeloid	myeloid	B-NP	JJ	B-cell_type	19	NMOD	B-cell_type
O	O	396	401	cells	cell	I-NP	NNS	I-cell_type	17	PMOD	I-cell_type
O	O	402	404	to	to	B-VP	TO	O	21	VMOD	O
O	O	405	409	form	form	I-VP	VB	O	16	VMOD	O
T13	B-Entity	410	420	inhibitory	inhibitory	B-NP	JJ	B-protein	23	NMOD	B-protein
T13	I-Entity	421	430	complexes	complex	I-NP	NNS	I-protein	21	OBJ	I-protein
O	O	431	435	that	that	B-NP	WDT	O	23	NMOD	O
O	O	436	442	hinder	hinder	B-VP	VBP	O	24	SBAR	O
O	O	443	458	transactivation	transactivation	B-NP	NN	O	25	OBJ	O
O	O	459	461	of	of	B-PP	IN	O	26	NMOD	O
T4	B-Protein	462	463	c	c	B-NP	NN	B-DNA	32	NMOD	B-DNA
T4	I-Protein	463	464	-	-	I-NP	HYPH	I-DNA	32	P	I-DNA
T4	I-Protein	464	467	Myb	Myb	I-NP	NN	I-DNA	32	NMOD	I-DNA
T14	B-Entity	468	474	target	target	I-NP	NN	I-DNA	32	NMOD	I-DNA
T14	I-Entity	475	480	genes	gene	I-NP	NNS	I-DNA	27	PMOD	I-DNA
O	O	481	488	through	through	B-PP	IN	O	25	VMOD	O
O	O	489	495	direct	direct	B-NP	JJ	O	35	NMOD	O
O	O	496	503	binding	binding	I-NP	NN	O	33	PMOD	O
O	O	504	506	to	to	B-PP	TO	O	35	NMOD	O
T15	B-Entity	507	510	Myb	Myb	B-NP	NN	B-DNA	39	NMOD	B-DNA
T15	I-Entity	511	520	consensus	consensus	I-NP	NN	I-DNA	39	NMOD	I-DNA
T15	I-Entity	521	526	sites	site	I-NP	NNS	I-DNA	36	PMOD	I-DNA
O	O	526	527	.	.	O	.	O	2	P	O

O	O	528	533	These	These	B-NP	DT	O	2	NMOD	O
O	O	534	543	complexes	complex	I-NP	NNS	O	3	SUB	O
O	O	544	549	arise	arise	B-VP	VBP	O	0	ROOT	O
O	O	550	552	in	in	B-PP	IN	O	10	VMOD	O
O	O	553	554	a	a	B-NP	DT	O	8	NMOD	O
O	O	555	570	developmentally	developmentally	I-NP	RB	O	7	AMOD	O
O	O	571	580	regulated	regulate	I-NP	VBN	O	8	NMOD	O
O	O	581	588	pattern	pattern	I-NP	NN	O	4	PMOD	O
O	O	588	589	,	,	O	,	O	10	P	O
O	O	590	597	peaking	peak	B-VP	VBG	O	22	VMOD	O
O	O	598	600	at	at	B-PP	IN	O	10	VMOD	O
O	O	601	604	the	the	B-NP	DT	O	14	NMOD	O
O	O	605	617	promyelocyte	promyelocyte	I-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	618	623	stage	stage	I-NP	NN	I-cell_type	11	PMOD	I-cell_type
O	O	623	624	,	,	O	,	O	10	P	O
O	O	625	627	or	or	O	CC	O	22	VMOD	O
O	O	628	630	in	in	B-PP	IN	O	22	VMOD	O
O	O	631	635	cell	cell	B-NP	NN	B-cell_line	20	NMOD	B-cell_line
O	O	636	641	model	model	I-NP	NN	I-cell_line	20	NMOD	I-cell_line
O	O	642	649	systems	system	I-NP	NNS	I-cell_line	17	PMOD	I-cell_line
O	O	649	650	,	,	O	,	O	22	P	O
O	O	651	660	appearing	appear	B-VP	VBG	O	3	VMOD	O
O	O	661	665	soon	soon	B-ADVP	RB	O	22	VMOD	O
O	O	666	671	after	after	B-PP	IN	O	23	PMOD	O
O	O	672	675	the	the	B-NP	DT	O	26	NMOD	O
O	O	676	685	induction	induction	I-NP	NN	O	24	PMOD	O
O	O	686	688	of	of	B-PP	IN	O	26	NMOD	O
O	O	689	698	monocytic	monocytic	B-NP	JJ	O	29	NMOD	O
O	O	699	714	differentiation	differentiation	I-NP	NN	O	27	PMOD	O
O	O	714	715	.	.	O	.	O	3	P	O

O	O	716	718	We	We	B-NP	PRP	O	2	SUB	O
O	O	719	725	wished	wish	B-VP	VBD	O	0	ROOT	O
O	O	726	728	to	to	I-VP	TO	O	4	VMOD	O
O	O	729	738	determine	determine	I-VP	VB	O	2	VMOD	O
O	O	739	741	if	if	B-SBAR	IN	O	4	VMOD	O
O	O	742	746	this	this	B-NP	DT	O	9	NMOD	O
O	O	747	762	developmentally	developmentally	I-NP	RB	O	8	AMOD	O
O	O	763	770	related	related	I-NP	JJ	O	9	NMOD	O
O	O	771	782	interaction	interaction	I-NP	NN	O	10	SUB	O
O	O	783	785	is	be	B-VP	VBZ	O	5	SBAR	O
O	O	786	787	a	a	B-NP	DT	O	12	NMOD	O
O	O	788	799	consequence	consequence	I-NP	NN	O	10	PRD	O
O	O	800	802	of	of	B-PP	IN	O	12	NMOD	O
O	O	803	810	myeloid	myeloid	B-NP	JJ	O	15	NMOD	O
O	O	811	826	differentiation	differentiation	I-NP	NN	O	20	NMOD	O
O	O	827	829	or	or	O	CC	O	20	NMOD	O
O	O	830	832	an	an	B-NP	DT	O	20	NMOD	O
O	O	833	842	intrinsic	intrinsic	I-NP	JJ	O	20	NMOD	O
O	O	843	858	differentiating	differentiate	I-NP	VBG	O	20	NMOD	O
O	O	859	867	stimulus	stimulus	I-NP	NN	O	13	PMOD	O
O	O	867	868	.	.	O	.	O	2	P	O

O	O	869	876	Because	Because	B-SBAR	IN	O	28	VMOD	O
O	O	877	880	the	the	B-NP	DT	O	7	NMOD	O
O	O	881	889	elevated	elevated	I-NP	JJ	O	7	NMOD	O
T16	B-Entity	890	893	Myb	Myb	I-NP	NN	B-protein	7	NMOD	B-protein
T16	I-Entity	893	894	:	:	O	:	O	7	P	O
T16	I-Entity	894	897	Maf	Maf	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	898	904	status	status	I-NP	NN	O	12	SUB	O
O	O	905	909	seen	see	B-VP	VBN	O	7	NMOD	O
O	O	910	912	in	in	B-PP	IN	O	8	VMOD	O
O	O	913	928	differentiating	differentiate	B-NP	VBG	B-cell_type	11	NMOD	B-cell_type
O	O	929	934	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	935	938	can	can	B-VP	MD	O	1	SBAR	O
O	O	939	941	be	be	I-VP	VB	O	12	VC	O
O	O	942	955	recapitulated	recapitulate	I-VP	VBN	O	13	VC	O
O	O	956	958	by	by	B-PP	IN	O	14	VMOD	O
O	O	959	973	overexpression	overexpression	B-NP	NN	O	15	PMOD	O
O	O	974	976	of	of	B-PP	IN	O	16	NMOD	O
T5	B-Protein	977	978	c	c	B-NP	NN	B-protein	20	NMOD	B-protein
T5	I-Protein	978	979	-	-	I-NP	HYPH	I-protein	20	NMOD	I-protein
T5	I-Protein	979	982	Maf	Maf	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	983	985	in	in	B-PP	IN	O	16	NMOD	O
O	O	986	993	myeloid	myeloid	B-NP	JJ	B-cell_line	24	NMOD	B-cell_line
O	O	994	998	cell	cell	I-NP	NN	I-cell_line	24	NMOD	I-cell_line
O	O	999	1004	lines	line	I-NP	NNS	I-cell_line	21	PMOD	I-cell_line
O	O	1004	1005	,	,	O	,	O	28	P	O
O	O	1006	1008	we	we	B-NP	PRP	O	28	SUB	O
O	O	1009	1018	inducibly	inducibly	B-ADVP	RB	O	28	VMOD	O
O	O	1019	1028	expressed	express	B-VP	VBD	O	0	ROOT	O
O	O	1029	1032	the	the	B-NP	DT	O	33	NMOD	O
T6	B-Protein	1033	1034	c	c	I-NP	NN	B-DNA	33	NMOD	B-DNA
T6	I-Protein	1034	1035	-	-	B-NP	HYPH	I-DNA	33	NMOD	I-DNA
T6	I-Protein	1035	1038	Maf	Maf	I-NP	NN	I-DNA	33	NMOD	I-DNA
O	O	1039	1043	cDNA	cDNA	I-NP	NN	I-DNA	28	OBJ	I-DNA
O	O	1044	1046	in	in	B-PP	IN	O	28	VMOD	O
O	O	1047	1048	2	2	B-NP	CD	O	40	NMOD	O
O	O	1049	1057	bipotent	bipotent	I-NP	JJ	O	40	NMOD	O
O	O	1058	1063	human	human	I-NP	JJ	B-cell_type	40	NMOD	B-cell_type
O	O	1064	1071	myeloid	myeloid	I-NP	JJ	I-cell_type	40	NMOD	I-cell_type
O	O	1072	1082	progenitor	progenitor	I-NP	NN	I-cell_type	40	NMOD	I-cell_type
O	O	1083	1088	cells	cell	I-NP	NNS	I-cell_type	34	PMOD	I-cell_type
O	O	1088	1089	.	.	O	.	O	28	P	O

O	O	1090	1098	Elevated	Elevated	B-NP	JJ	O	2	NMOD	O
O	O	1099	1105	levels	level	I-NP	NNS	O	8	SUB	O
O	O	1106	1108	of	of	B-PP	IN	O	2	NMOD	O
T7	B-Protein	1109	1110	c	c	B-NP	NN	B-protein	7	NMOD	B-protein
T7	I-Protein	1110	1111	-	-	I-NP	HYPH	I-protein	7	NMOD	I-protein
T7	I-Protein	1111	1114	Maf	Maf	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	1115	1122	protein	protein	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	1123	1126	led	lead	B-VP	VBD	O	0	ROOT	O
O	O	1127	1129	to	to	B-PP	TO	O	8	VMOD	O
O	O	1130	1136	marked	marked	B-NP	JJ	O	11	NMOD	O
O	O	1137	1146	increases	increase	I-NP	NNS	O	19	NMOD	O
O	O	1147	1149	in	in	B-PP	IN	O	11	NMOD	O
T17	B-Entity	1150	1153	Myb	Myb	B-NP	NN	B-protein	16	NMOD	B-protein
T17	I-Entity	1153	1154	:	:	O	:	I-protein	16	P	I-protein
T17	I-Entity	1154	1157	Maf	Maf	B-NP	NN	I-protein	16	NMOD	I-protein
T17	I-Entity	1158	1167	complexes	complex	I-NP	NNS	I-protein	12	PMOD	I-protein
O	O	1168	1171	and	and	O	CC	O	19	NMOD	O
O	O	1172	1175	the	the	B-NP	DT	O	19	NMOD	O
O	O	1176	1188	accumulation	accumulation	I-NP	NN	O	9	PMOD	O
O	O	1189	1191	of	of	B-PP	IN	O	19	NMOD	O
O	O	1192	1200	monocyte	monocyte	B-NP	NN	B-cell_type	24	NMOD	B-cell_type
O	O	1200	1201	/	/	O	SYM	I-cell_type	24	NMOD	I-cell_type
O	O	1201	1211	macrophage	macrophage	B-NP	NN	I-cell_type	24	NMOD	I-cell_type
O	O	1212	1217	cells	cell	I-NP	NNS	I-cell_type	20	PMOD	I-cell_type
O	O	1217	1218	,	,	O	,	O	19	P	O
O	O	1219	1227	followed	follow	B-VP	VBN	O	19	NMOD	O
O	O	1228	1230	by	by	B-PP	IN	O	26	VMOD	O
O	O	1231	1239	eventual	eventual	B-NP	JJ	O	31	NMOD	O
O	O	1240	1250	programmed	program	I-NP	VBN	O	31	NMOD	O
O	O	1251	1255	cell	cell	I-NP	NN	O	31	NMOD	O
O	O	1256	1261	death	death	I-NP	NN	O	27	PMOD	O
O	O	1261	1262	.	.	O	.	O	8	P	O

O	O	1263	1271	Analysis	Analysis	B-NP	NN	O	10	SUB	O
O	O	1272	1274	of	of	B-PP	IN	O	1	NMOD	O
O	O	1275	1282	targets	target	B-NP	NNS	O	2	PMOD	O
O	O	1283	1287	that	that	B-NP	WDT	O	3	NMOD	O
O	O	1288	1293	could	could	B-VP	MD	O	4	SBAR	O
O	O	1294	1301	mediate	mediate	I-VP	VB	O	5	VC	O
O	O	1302	1307	these	these	B-NP	DT	O	9	NMOD	O
O	O	1308	1318	phenotypic	phenotypic	I-NP	JJ	O	9	NMOD	O
O	O	1319	1326	changes	change	I-NP	NNS	O	6	OBJ	O
O	O	1327	1336	indicated	indicate	B-VP	VBD	O	0	ROOT	O
O	O	1337	1341	that	that	B-SBAR	IN	O	10	VMOD	O
T8	B-Protein	1342	1343	c	c	B-NP	NN	B-protein	14	NMOD	B-protein
T8	I-Protein	1343	1344	-	-	O	HYPH	I-protein	14	NMOD	I-protein
T8	I-Protein	1344	1347	Maf	Maf	B-NP	NN	I-protein	16	SUB	I-protein
O	O	1348	1354	likely	likely	B-ADVP	RB	O	16	VMOD	O
O	O	1355	1360	plays	play	B-VP	VBZ	O	11	SBAR	O
O	O	1361	1362	a	a	B-NP	DT	O	19	NMOD	O
O	O	1363	1366	key	key	I-NP	JJ	O	19	NMOD	O
O	O	1367	1371	role	role	I-NP	NN	O	16	OBJ	O
O	O	1372	1374	in	in	B-PP	IN	O	16	VMOD	O
O	O	1375	1382	myeloid	myeloid	B-NP	JJ	O	23	NMOD	O
O	O	1383	1387	cell	cell	I-NP	NN	O	23	NMOD	O
O	O	1388	1399	development	development	I-NP	NN	O	20	PMOD	O
O	O	1400	1407	through	through	B-PP	IN	O	16	VMOD	O
O	O	1408	1412	dual	dual	B-NP	JJ	O	26	NMOD	O
O	O	1413	1423	mechanisms	mechanism	I-NP	NNS	O	28	NMOD	O
O	O	1423	1424	;	;	O	:	O	26	P	O
O	O	1425	1435	inhibition	inhibition	B-NP	NN	O	24	PMOD	O
O	O	1436	1438	of	of	B-PP	IN	O	28	NMOD	O
O	O	1439	1440	a	a	B-NP	DT	O	32	NMOD	O
O	O	1441	1447	select	select	I-NP	JJ	O	32	NMOD	O
O	O	1448	1451	set	set	I-NP	NN	O	29	PMOD	O
O	O	1452	1454	of	of	B-PP	IN	O	32	NMOD	O
T9	B-Protein	1455	1456	c	c	B-NP	NN	B-protein	38	NMOD	B-protein
T9	I-Protein	1456	1457	-	-	I-NP	HYPH	I-protein	38	NMOD	I-protein
T9	I-Protein	1457	1460	Myb	Myb	I-NP	NN	I-protein	38	NMOD	I-protein
T18	B-Entity	1461	1470	regulated	regulate	I-NP	VBN	O	38	NMOD	O
T18	I-Entity	1471	1478	targets	target	I-NP	NNS	O	33	PMOD	O
O	O	1478	1479	,	,	O	,	O	38	P	O
O	O	1480	1484	such	such	B-PP	JJ	O	41	PMOD	O
O	O	1485	1487	as	as	I-PP	IN	O	38	NMOD	O
T10	B-Protein	1488	1491	Bcl	Bcl	B-NP	NN	B-protein	48	NMOD	B-protein
T10	I-Protein	1491	1492	-	-	O	HYPH	I-protein	42	NMOD	I-protein
T10	I-Protein	1492	1493	2	2	B-NP	CD	I-protein	48	NMOD	I-protein
O	O	1494	1497	and	and	O	CC	O	48	NMOD	O
T11	B-Protein	1498	1502	CD13	CD13	B-NP	NN	B-protein	48	NMOD	B-protein
O	O	1502	1503	/	/	B-NP	SYM	O	48	NMOD	O
T12	B-Protein	1503	1506	APN	APN	I-NP	NN	B-protein	41	PMOD	B-protein
O	O	1506	1507	,	,	O	,	O	48	P	O
O	O	1508	1515	coupled	couple	B-VP	VBN	O	48	NMOD	O
O	O	1516	1520	with	with	B-PP	IN	O	50	VMOD	O
O	O	1521	1524	the	the	B-NP	DT	O	53	NMOD	O
O	O	1525	1535	activation	activation	I-NP	NN	O	51	PMOD	O
O	O	1536	1538	of	of	B-PP	IN	O	53	NMOD	O
O	O	1539	1541	as	as	B-NP	RB	O	57	AMOD	O
O	O	1542	1545	yet	yet	I-NP	RB	O	57	AMOD	O
O	O	1546	1555	undefined	undefined	I-NP	JJ	O	54	PMOD	O
T19	B-Entity	1556	1571	differentiation	differentiation	I-NP	NN	O	61	NMOD	O
T19	I-Entity	1571	1572	-	-	O	HYPH	O	58	P	O
T19	I-Entity	1572	1581	promoting	promote	B-VP	VBG	B-DNA	61	NMOD	B-DNA
T19	I-Entity	1582	1587	genes	gene	B-NP	NNS	I-DNA	57	NMOD	I-DNA
O	O	1587	1588	.	.	O	.	O	10	P	O
